Global Active Pharmaceutical Ingredients (API) Market
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Global</strong> <strong>Active</strong> <strong>Pharmaceutical</strong> <strong>Ingredients</strong> (<strong>API</strong>) <strong>Market</strong>, 2014 - 2020<br />
development program for biologics is less as compared to chemical <strong>API</strong>s, primarily because of high<br />
success rates in the pipeline phase. This factor has attracted higher investments in the biologics and<br />
biosimilars market.<br />
Apart from the currently marketed blockbuster biologics such as Humira and Herceptin, several other<br />
promising biologics such as mepolizumab (GSK), dupilumab (Sanofi/Regeron), alirocumab (Sanofi),<br />
evolocumab (Amgen), brodalumab (Amgen), ixekizumab (Eli Lilly) and secukinumab (Novartis) are<br />
expected to enter different geographical markets during the forecast period from 2015 to 2020. Presently,<br />
most of the biologics are manufactured in-house due to intellectual property concerns and quality issues.<br />
However, the manufacturing of biological <strong>API</strong>s is a very complex and challenging process. Hence,<br />
innovator companies are outsourcing to contract manufacturing companies with biological production<br />
expertise.<br />
Teva <strong>Pharmaceutical</strong> Industries Ltd dominated active pharmaceutical ingredients market in 2014. Major<br />
factors attributed to its dominance are broad product portfolio and high market penetration. Zhejiang<br />
Medicine Co., Ltd. and Zhejiang NHU Co., Ltd secured the second market position in 2015. North China<br />
<strong>Pharmaceutical</strong> Group Corp. (NCPC) and Northeast <strong>Pharmaceutical</strong> Group Co., Ltd. held the third<br />
position in 2015. Other players in the active pharmaceutical ingredients market include Dr.Reddy's<br />
Laboratories Limited, Sandoz (Novartis AG), Aurobindo Pharma Limited, Zhejiang Hisun <strong>Pharmaceutical</strong><br />
Co., Ltd. and Zhejiang Huahai <strong>Pharmaceutical</strong>s Co., Ltd. and others<br />
About Us<br />
Persistence <strong>Market</strong> Research (PMR) is a third-platform research firm. Our research model is a<br />
unique collaboration of data analytics and market research methodology to help businesses<br />
achieve optimal performance.<br />
To support companies in overcoming complex business challenges, we follow a multidisciplinary<br />
approach. At PMR, we unite various data streams from multi-dimensional sources.<br />
By deploying real-time data collection, big data, and customer experience analytics, we deliver<br />
business intelligence for organizations of all sizes.<br />
Contact<br />
Persistence <strong>Market</strong> Research 6
Change language